Scott L. Letendre

979 total citations
32 papers, 656 citations indexed

About

Scott L. Letendre is a scholar working on Virology, Emergency Medicine and Infectious Diseases. According to data from OpenAlex, Scott L. Letendre has authored 32 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 16 papers in Emergency Medicine and 13 papers in Infectious Diseases. Recurrent topics in Scott L. Letendre's work include HIV Research and Treatment (22 papers), HIV-related health complications and treatments (16 papers) and HIV/AIDS Research and Interventions (10 papers). Scott L. Letendre is often cited by papers focused on HIV Research and Treatment (22 papers), HIV-related health complications and treatments (16 papers) and HIV/AIDS Research and Interventions (10 papers). Scott L. Letendre collaborates with scholars based in United States, Australia and Italy. Scott L. Letendre's co-authors include Mariana Cherner, Robert K. Heaton, Igor Grant, Robert K. Heaton, Ronald J. Ellis, J. Marquie-Beck, Janis Durelle, Thomas D. Marcotte, Anya Umlauf and Igor Grant and has published in prestigious journals such as PLoS ONE, Neurology and Clinical Infectious Diseases.

In The Last Decade

Scott L. Letendre

28 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott L. Letendre United States	13	391	270	228	130	76	32	656
Mark D. Kelly Australia	8	539 1.4×	330 1.2×	168 0.7×	108 0.8×	74 1.0×	17	789
Jennifer Marquie‐Beck United States	14	441 1.1×	269 1.0×	214 0.9×	131 1.0×	102 1.3×	18	699
Kathryn N. Devlin United States	17	326 0.8×	190 0.7×	172 0.8×	79 0.6×	81 1.1×	29	654
Robert A. Velin United States	8	599 1.5×	384 1.4×	257 1.1×	99 0.8×	113 1.5×	9	922
Corinna Young United States	9	223 0.6×	257 1.0×	212 0.9×	94 0.7×	25 0.3×	11	475
R Deutsch United States	7	241 0.6×	161 0.6×	140 0.6×	178 1.4×	60 0.8×	9	537
J. Marquie-Beck United States	6	294 0.8×	206 0.8×	174 0.8×	93 0.7×	48 0.6×	6	407
Jeffery R. Alger United States	9	471 1.2×	246 0.9×	316 1.4×	107 0.8×	69 0.9×	12	694
Benedetta Milanini United States	13	425 1.1×	257 1.0×	323 1.4×	66 0.5×	93 1.2×	25	561
Nichole A. Duarte United States	11	231 0.6×	242 0.9×	156 0.7×	101 0.8×	51 0.7×	12	511

Countries citing papers authored by Scott L. Letendre

Since Specialization

Citations

This map shows the geographic impact of Scott L. Letendre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott L. Letendre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott L. Letendre more than expected).

Fields of papers citing papers by Scott L. Letendre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott L. Letendre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott L. Letendre. The network helps show where Scott L. Letendre may publish in the future.

Co-authorship network of co-authors of Scott L. Letendre

This figure shows the co-authorship network connecting the top 25 collaborators of Scott L. Letendre. A scholar is included among the top collaborators of Scott L. Letendre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott L. Letendre. Scott L. Letendre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hestad, Knut, J. Anitha Menon, Ravi Paul, et al.. (2025). Predictors of cognitive performance in Zambian adults with clade C HIV-1: The roles of antiretroviral therapy (ART)-induced CD4+ T-cell increase and pulmonary tuberculosis.. Neuropsychology. 39(5). 375–383.

Trunfio, Mattia, et al.. (2024). Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study. AIDS and Behavior. 28(11). 3643–3654. 1 indexed citations

Trunfio, Mattia, Bin Tang, Jennifer E. Iudicello, et al.. (2023). Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIV. The Journal of Infectious Diseases. 229(5). 1266–1276. 2 indexed citations

Sundermann, Erin E., Raha Dastgheyb, David J. Moore, et al.. (2023). Identifying and distinguishing cognitive profiles among virally suppressed people with HIV.. Neuropsychology. 38(2). 169–183. 2 indexed citations

Deme, Pragney, et al.. (2022). Association of Plasma Eicosanoid Levels With Immune, Viral, and Cognitive Outcomes in People With HIV. Neurology. 99(12). e1251–e1264. 2 indexed citations

Sundermann, Erin E., Rowan Saloner, Anna Rubtsova, et al.. (2022). The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV. Journal of NeuroVirology. 28(3). 410–421. 9 indexed citations

Almeida, Sérgio Monteiro de, Indianara Rotta, Luine Rosele Vidal, et al.. (2021). HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil. Journal of NeuroVirology. 27(1). 126–136. 13 indexed citations

Saloner, Rowan, Emily W. Paolillo, Robert K. Heaton, et al.. (2021). Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV. Journal of NeuroVirology. 27(1). 160–167. 14 indexed citations

Walter, T. Jordan, Jared W. Young, Robert K. Heaton, et al.. (2020). Both HIV and Tat expression decrease prepulse inhibition with further impairment by methamphetamine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 106. 110089–110089. 9 indexed citations

10.

Saloner, Rowan, Anya Umlauf, Erin E. Morgan, et al.. (2020). Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV. AIDS and Behavior. 24(11). 3071–3082. 10 indexed citations

11.

Paolillo, Emily W., Rowan Saloner, Jessica L. Montoya, et al.. (2019). Frailty in Comorbid HIV and Lifetime Methamphetamine Use Disorder: Associations with Neurocognitive and Everyday Functioning. AIDS Research and Human Retroviruses. 35(11-12). 1044–1053. 10 indexed citations

12.

Minassian, Arpi, Brook L. Henry, Jennifer E. Iudicello, et al.. (2017). Everyday functional ability in HIV and methamphetamine dependence. Drug and Alcohol Dependence. 175. 60–66. 10 indexed citations

13.

Dickens, Alex M., Daniel C. Anthony, Michelle M. Mielke, et al.. (2014). Longitudinal changes in CSF metabolites as a prognostic marker for cognition in HIV-infected patients. Journal of Neuroimmune Pharmacology. 9. 13–13. 1 indexed citations

14.

Cattie, Jordan E., Scott L. Letendre, Steven Paul Woods, et al.. (2014). Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment. Journal of NeuroVirology. 20(6). 561–570. 26 indexed citations

15.

Ellis, Ronald J., Scott L. Letendre, Florin Vaida, et al.. (2013). Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder. Clinical Infectious Diseases. 58(7). 1015–1022. 92 indexed citations

16.

Spector, Stephen A., Kumud K. Singh, Saurabh Gupta, et al.. (2010). APOE ε4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. AIDS. 24(10). 1471–1479. 42 indexed citations

17.

Cherner, Mariana, Chad Bousman, Ian Everall, et al.. (2010). Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: Preliminary findings. Journal of the International Neuropsychological Society. 16(5). 890–901. 38 indexed citations

18.

Dawes, Sharron E., Paola Suárez, Mariana Cherner, et al.. (2008). Variable patterns of neuropsychological performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology. 30(6). 613–626. 96 indexed citations

19.

Vigil, Ofilio, Steven Paul Woods, J. Hampton Atkinson, et al.. (2008). Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection. Journal of Clinical and Experimental Neuropsychology. 30(7). 805–815. 30 indexed citations

20.

Podzamczer, Daniel, Martin King, Cheri E. Klein, et al.. (2007). High-Dose Lopinavir/Ritonavir in Highly Treatment-Experienced HIV-1 Patients: Efficacy, Safety, and Predictors of Response. HIV Clinical Trials. 8(4). 193–204. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact